INMED PHARMACEUTICALS INC. Cost of Goods and Services Sold
INMED PHARMACEUTICALS INC. (INM) reported Cost of Goods and Services Sold of $745.58 thousand for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-13.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2024-02-13
- INMED PHARMACEUTICALS INC. cost of goods and services sold for the quarter ending 2023-12-31 was $745.58K, a 120.18% increase year-over-year.
- INMED PHARMACEUTICALS INC. cost of goods and services sold for the quarter ending 2023-09-30 was $787.69K, a 235.14% increase year-over-year.
- INMED PHARMACEUTICALS INC. cost of goods and services sold for the quarter ending 2022-12-31 was $338.62K.
- INMED PHARMACEUTICALS INC. cost of goods and services sold for the quarter ending 2022-09-30 was $235.03K.
- INMED PHARMACEUTICALS INC. cost of goods and services sold for fiscal 2022 was $545.89K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|
| 2023-12-31 | $745.58K 10-Q · filed 2024-02-13 | $1.53M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $787.69K 10-Q · filed 2023-11-14 | ||
| 2022-12-31 | $338.62K 10-Q · filed 2024-02-13 | $573.65K 10-Q · filed 2024-02-13 | |
| 2022-09-30 | $235.03K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $545.89K 10-K · filed 2022-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |